Matteo Cerboneschi | Emerging Technologies Shaping Longevity | Milan Longevity Summit 2026

*Estrogens in Menopause: From the Genome to the Metabolome* Why do women experience menopause so differently—and can data help us understand why? In this session from *Emerging Technologies Shaping Longevity* at the *Milan Longevity Summit 2026*, *Matteo Cerboneschi* explores how genomics and metabolomics can deepen our understanding of estrogen biology and the profound changes that occur during menopause. Menopause is not a uniform biological experience. Genetics, metabolism, hormonal pathways, lifestyle, and individual physiology all influence how women respond to declining estrogen levels. By connecting information from the genome to the metabolome, new technologies are making it possible to build a more detailed picture of these differences. Cerboneschi examines how this data-driven approach could support a new generation of more personalised strategies for women's health, moving beyond one-size-fits-all approaches to menopause and healthy ageing. Matteo Cerboneschi is Founder and CEO of *Personalife*, where his work focuses on applying molecular data and personalised health technologies to better understand individual differences in health, metabolism, and ageing. The Milan Longevity Summit brings together global leaders across science, medicine, policy, business, technology and society to rethink the future of health through a *One Health* perspective—recognising that the wellbeing of people, planet and economies is deeply interconnected. **Learn more about the Milan Longevity Summit:** https://www.milanlongevitysummit.org/it/speakers26/matteo-cerboneschi #MilanLongevitySummit #Longevity #OneHealth #MatteoCerboneschi #Menopause #WomensHealth #Genomics #Metabolomics #PrecisionMedicine #HealthyAgeing #femtech #femgevity